The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression

被引:0
|
作者
Paxton, WA [1 ]
Kang, S [1 ]
Koup, RA [1 ]
机构
[1] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The purified CD4(+) lymphocytes of a group of highly exposed but HIV-1-uninfected individuals mere determined to be less susceptible to infection with multiple non-syncytium-inducing (NSI) primary isolates of HIV-1 than were CD4(+) lymphocytes from nonexposed control individuals. This relative resistance to HIV-1 infection did not extend to T cell line-adapted or syncytium-inducing (SI) primary viral isolates, mas restricted by the envelope glycoprotein, and was associated with an increased production of the C-C chemokines RANTES, MIP-1 alpha, and MIP-1 beta, The block to replication in CD4(+) lymphocytes from two exposed-uninfected subjects was at the point of entry, as was the block imposed by the recombinant C-C chemokines RANTES, MIP-1 alpha, and MIP-1 beta, Resistance to infection and the high production of beta chemokines were characteristic of every CD4(+) lymphocyte clone from the exposed-uninfected subjects. We have now identified the mechanism underlying this in vitro and in vivo resistance to infection: These individuals have inherited a homozygous 32-bp nucleotide deletion (Delta 32) within the gene encoding the coreceptor for primary NSI isolates of HIV-1 (CCR5), This deletion encodes a severely truncated and unstable protein that is not expressed on the cell surface. This allele is common in the Caucasian population, with a frequency of 0.0808, but is not found in people of African or Asian ancestry. To determine its role in HIV-1 transmission and disease progression, me analyzed the CCR5 genotype of 1252 homosexual men enrolled in the Chicago component of the Multicenter AIDS Cohort Study (MACS), No infected participant was found to be homozygous for the Delta 32 allele whereas 3.6% of at-risk but uninfected Caucasian participants were homozygous, showing the highly protective role of this genotype against sexual acquisition of HIV-1, No evidence was found to suggest that heterozygotes mere protected against HIV-1 infection, but a limited protective role against disease progression was noted. The Delta 32 allele of CCR5 is therefore an important host factor in HIV-1 transmission and pathogenesis.
引用
收藏
页码:S89 / S92
页数:4
相关论文
共 50 条
  • [41] Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates
    Albright, AV
    Shieh, JTC
    Itoh, T
    Lee, B
    Pleasure, D
    O'Connor, MJ
    Doms, RW
    González-Scarano, F
    JOURNAL OF VIROLOGY, 1999, 73 (01) : 205 - 213
  • [42] Maraviroc, a CCR5 Coreceptor Antagonist That Blocks Entry of Human Immunodeficiency Virus Type 1
    Hunt, Joshua S.
    Romanelli, Frank
    PHARMACOTHERAPY, 2009, 29 (03): : 295 - 304
  • [43] DNA polymorphism of HIV coreceptor CCR5 gene in HIV infected patients and in general population
    Kemény, B
    Nagy, K
    Horváth, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 617 - 617
  • [44] Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity
    Foda, M
    Harada, S
    Maeda, Y
    MICROBIOLOGY AND IMMUNOLOGY, 2001, 45 (07) : 521 - 530
  • [45] Detection of New Mutant Sites of HIV-1 Coreceptor CCR5 Among Saudi Populations
    Abuelsaad, Abdelaziz S. A.
    Al-Ghamdi, Abdullhamid S.
    Al-Ghamdi, Ahmed N.
    Alakkas, Eyad A.
    Alsulaimani, Adnan A.
    Al-Harthi, Abdulla A.
    Abdel-Moneim, Ahmed S.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2013, 33 (12): : 783 - 789
  • [46] Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES
    Nisius, Lydia
    Rogowski, Marco
    Vangelista, Luca
    Grzesiek, Stephan
    PROTEIN EXPRESSION AND PURIFICATION, 2008, 61 (02) : 155 - 162
  • [47] Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity
    Blanpain, C
    Lee, B
    Vakili, J
    Doranz, BJ
    Govaerts, C
    Migeotte, I
    Sharron, M
    Dupriez, V
    Vassart, G
    Doms, RW
    Parmentier, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) : 18902 - 18908
  • [48] HIV-1 infectability of CD4+ lymphocytes with relation to β-chemokines and the CCR5 coreceptor
    Paxton, WA
    Kang, S
    Liu, R
    Landau, NR
    Gingeras, TR
    Wu, LJ
    Mackay, CR
    Koup, RA
    IMMUNOLOGY LETTERS, 1999, 66 (1-3) : 71 - 75
  • [49] Vitamin E supplementation increases the expression of the CCR5 coreceptor in HIV-1 infected subjects
    PierrePortales
    Guerrier, T
    Clot, J
    Corbeau, P
    Mettling, C
    Lin, YL
    Baillat, V
    de Boever, CM
    Moing, VL
    Tramoni, C
    Reynes, J
    Segondy, M
    CLINICAL NUTRITION, 2004, 23 (05) : 1244 - 1245
  • [50] Extracellular cysteines of CCR5 are required for chemokine binding, but, dispensable for HIV-1 coreceptor activity
    Blanpain, Cedric
    Lee, Benhur
    Vakili, Jalal
    Doranz, Benjamin J.
    Govaerts, Cedric
    Migeotte, Isabelle
    Sharron, Matthew
    Dupriez, Vincent
    Vassart, Gilbert
    Doms, Robert W.
    Parmentier, Marc
    Journal of Biological Chemistry, 274 (27): : 18902 - 18908